Adherence patterns with first- versus second-generation antipsychotics for newly diagnosed schizophrenia in Taiwan

Psychiatric Services

Volumn 63, Issue 5, 2012, Pages 504-507

  Chang, Chia Ming ^a   Wu, Kuan Yi ^a   Liang, Hsin Yi ^a   Wu, Erin Chia Hsuan ^b   Chen, Chuan Yu ^c,d   Wu, Chi Shin ^e   Chen, Shaw Ji ^f   Chang, Tsung Kai ^c   Tsai, Hui Ju ^d,g  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^e FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^f TZU CHI UNIVERSITY   (Taiwan)

^g NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; CHLORPROMAZINE; CHLORPROTHIXENE; CLOPENTHIXOL; CLOTIAPINE; CLOZAPINE; DROPERIDOL; FLUPENTIXOL; FLUPHENAZINE; HALOPERIDOL; LOXAPINE; NEUROLEPTIC AGENT; OLANZAPINE; PENFLURIDOL; PERPHENAZINE; PIMOZIDE; PIPOTIAZINE; QUETIAPINE; RISPERIDONE; SULPIRIDE; THIORIDAZINE; TIOTIXENE; TRIFLUOPERAZINE; ZIPRASIDONE; ZOTEPINE; ZUCLOPENTHIXOL;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG WITHDRAWAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NATIONAL HEALTH INSURANCE; SCHIZOPHRENIA; TAIWAN;

ADULT; ANTIPSYCHOTIC AGENTS; DRUG PRESCRIPTIONS; DRUG SUBSTITUTION; HUMANS; INSURANCE, HEALTH; LOGISTIC MODELS; MEDICATION ADHERENCE; RETROSPECTIVE STUDIES; SCHIZOPHRENIA; TAIWAN;

EID: 84860711157     PISSN: 10752730     EISSN: 15579700     Source Type: Journal    
DOI: 10.1176/appi.ps.201100011     Document Type: Article

References (15)

1. Lacro JP, Dunn LB, Dolder CR, et al: Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. Journal of Clinical Psychiatry 63:892-909, 2002 (Pubitemid 35231730)
2. Robinson D: Predictors of medication discontinuation by patients with first-episode schizophrenia and schizoaffective disorder. Schizophrenia Research 57:209-219, 2002
3. Weiden PJ, Kozma C, Grogg A, et al: Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia. Psychiatric Services 55:886-891, 2004 (Pubitemid 39025215)
4. Ward A, Ishak K, Proskorovsky I, et al: Compliance with refilling prescriptions for atypical antipsychotic agents and its association with the risks for hospitalization, suicide, and death in patients with schizophrenia in Quebec and Saskatchewan: a retrospective database study. Clinical Therapeutics 28:1912-1921, 2006 (Pubitemid 46038522)
5. Dolder CR, Lacro JP, Dunn LB, et al: Antipsychotic medication adherence: is there a difference between typical and atypical agents? American Journal of Psychiatry 159:103-108, 2002 (Pubitemid 41070734)
6. Cooper D, Moisan J, Gregoire J-P: Adherence to atypical antipsychotic treatment among newly treated patients: a population-based study in schizophrenia. Journal of Clinical Psychiatry 68:818-825, 2007 (Pubitemid 47015479)
7. Vanelli M, Burstein P, Cramer J: Refill patterns of atypical and conventional antipsychotic medications at a national retail pharmacy chain. Psychiatric Services 52:1248-1250, 2001 (Pubitemid 32823200)
8. Mirandola M, Andretta M, Corbari L, et al: Prevalence, incidence and persistence of antipsychotic drug prescribing in the Italian general population: retrospective database analysis, 1999-2002. Pharmacoepidemiology and Drug Safety 15:412-420, 2005 (Pubitemid 44018700)
9. Ren XS, Qian S, Lee AF, et al: Treatment persistence: a comparison among patients with schizophrenia who were initiated on atypical antipsychotic agents. Journal of Clinical Pharmacy Therapeutics 31:57-65, 2006
10. Rothbard AB, Kuno E, Foley K: Trends in the rate and type of antipsychotic medications prescribed to persons with schizophrenia. Schizophrenia Bulletin 29:531-540, 2003 (Pubitemid 37339387)
11. Rijcken CA, Tobi H, Vergouwen AC, et al: Refill rate of antipsychotic drugs: an easy and inexpensive method to monitor patients'compliance by using computerised pharmacy data. Pharmacoepidemiology and Drug Safety 13:365-370, 2004 (Pubitemid 38787155)
12. Menzin J, Boulanger L, Friedman M, et al: Treatment adherence associated with conventional and atypical antipsychotics in a large state Medicaid program. Psychiatric Services 54:719-723, 2003 (Pubitemid 36752965)
13. Hugenholtz GWK, Heerdink ER, Nolen WA, et al: Less medication switching after initial start with atypical antipsychotics. European Neuropsychopharmacology 14:1-5, 2004 (Pubitemid 37495025)
14. Sim K, Su A, Leong JY, et al: High dose antipsychotic use in schizophrenia: findings of the REAP (Research on East Asia Psychotropic Prescriptions) study. Pharmacopsychiatry 37:175-179, 2004 (Pubitemid 38916427)
15. Lin TY: Psychiatry and Chinese culture. Western Journal of Medicine 139:862-867, 1983